01 1Zydus Lifesciences
01 1LETROZOLE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-23
Pay. Date : 2024-11-27
DMF Number : 40746
Submission : 2024-11-18
Status : Active
Type : II
20
Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LETROZOLE USP, with a corresponding US DMF Number 40746.
Remarkably, this DMF maintains an Active status since its submission on November 18, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 23, 2024, and payment made on November 27, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
